“…mHTT isolated from the CSF of HD subjects or BACHD rats is seeding-competent ( Tan et al, 2015 ; Lee et al, 2020 ), suggesting that mHTT aggregates may propagate to peripheral tissues and mediate systemic HD pathologies ( Chuang and Demontis, 2021 ). Heterogeneity in the structure and toxicity of mHTT aggregates ( Shen et al, 2016 ; Ko et al, 2018 ; Mario Isas et al, 2021 ) implies the existence of mHTT strains that could be linked to variability in seeding ability or clinical HD phenotypes as seen for other amyloid aggregates ( Tarutani et al, 2022 ). Interestingly, lesions formed by other pathogenic proteins, such as tau and α-synuclein, are also present in HD patient brains ( Jellinger, 1998 ; Charles et al, 2000 ) and appear in fetal graft tissue ( Cisbani et al, 2017 ; Ornelas et al, 2020 ), suggesting common pathways driving protein aggregation in these diseases.…”